Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Talis Biomedical Corporation TLIS
$0.52
-$0 (-0.04%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
14174976.00000000
-
week52high
1.34
-
week52low
0.42
-
Revenue
3652000
-
P/E TTM
0
-
Beta
1.07532100
-
EPS
-4.58000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 10:59
Описание компании
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| BTIG | Sell | Neutral | 18 мар 2022 г. |
| B of A Securities | Underperform | Underperform | 16 мар 2022 г. |
| B of A Securities | Underperform | Neutral | 07 янв 2022 г. |
| JP Morgan | Underweight | Neutral | 27 сент 2021 г. |
| Piper Sandler | Neutral | Overweight | 12 авг 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Scott Randal W. | A | 95000 | 95000 | 10 июн 2022 г. |
| Popovits Kimberly J | A | 95000 | 95000 | 10 июн 2022 г. |
| Posard Matthew L. | A | 95000 | 95000 | 10 июн 2022 г. |
| Ismagilov Rustem F. | A | 95000 | 95000 | 10 июн 2022 г. |
| Gilliam Melissa | A | 95000 | 95000 | 10 июн 2022 г. |
| BAKER BROS. ADVISORS LP | A | 95000 | 95000 | 10 июн 2022 г. |
| Kelley Robert J. | A | 723560 | 723560 | 01 июн 2022 г. |
| Moody John Roger Jr | A | 500000 | 500000 | 01 июн 2022 г. |
| Kelley Robert J. | A | 450000 | 450000 | 08 дек 2021 г. |
| Blaser Brian J | A | 625000 | 625000 | 01 дек 2021 г. |
Новостная лента
Talis Biomedical Corporation (TLIS) CEO Rob Kelly on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
05 авг 2022 г. в 15:48
Talis Biomedical Corporation (NASDAQ:TLIS ) Q2 2022 Earnings Conference Call August 1, 2022 4:30 PM ET Company Participants Emily Faucette - Senior Vice President, Corporate Communications & Investor Relations Rob Kelley - Chief Executive Officer Roger Moody - Chief Financial Officer Conference Call Participants Casey Woodring - JPMorgan Mike Ryskin - Bank of America Mark Massaro - BTIG Operator Good day and thank you for standing by. Welcome to the Talis Biomedical's Business Update Conference Call.
Talis Biomedical Corporation(TLIS) CEO Rob Kelly on Q12022 Results - Earnings Call Transcript
Seeking Alpha
15 мая 2022 г. в 11:08
Talis Biomedical Corporation (NASDAQ:TLIS ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Emily Faucette - SVP-Corporate Communications and IR Rob Kelley - CEO Roger Moody - CFO Conference Call Participants Rachel Vatnsdal - JPMorgan Derik De Bruin - Bank of America Mark Massaro - BTIG Operator Thank you all for standing by, and welcome to Talis's First Quarter 2022 Earnings Conference Call. [Operator Instructions] I'll now turn the call over to your host, Emily Faucette.
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022
GlobeNewsWire
26 апр 2022 г. в 08:00
MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that it will report first quarter financial results on Tuesday, May 10, 2022, after market close. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
Talis Biomedical stock bounces off record low after largest shareholder pulls share-sale plans
Market Watch
25 апр 2022 г. в 12:08
Shares of Talis Biomedical Corp. TLIS, +2.34% bounced 1.9% in midday trading Monday, after the diagnostic testing company requested a withdrawal of a large share offering by a selling shareholder. After the March 15 closing bell, the company had registered 37.49 million common shares for sale, including 7.63 million common shares and 29.86 million shares issuable after the conversion of convertible preferred stock, by entities affiliated with Baker Bros.
Talis Biomedical Corporation (TLIS) CEO Rob Kelly on Q4 2021 Results - Earnings Call Transcript
Seeking Alpha
15 мар 2022 г. в 22:09
Talis Biomedical Corporation (TLIS) CEO Rob Kelly on Q4 2021 Results - Earnings Call Transcript